4.7 Article

Factors Associated With Complications of Clostridium difficile Infection in a Multicenter Prospective Cohort

期刊

CLINICAL INFECTIOUS DISEASES
卷 61, 期 12, 页码 1781-1788

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/cid/civ749

关键词

Clostridium difficile; complications; mortality; risk factors; ribotype 027

资金

  1. Canadian Institutes of Health Research [MOP-74514]
  2. Fonds de recherche du Quebec-Sante

向作者/读者索取更多资源

Background. Clostridium difficile infection (CDI) is the most common cause of nosocomial infectious diarrhea and may result in severe complications including death. We conducted a prospective study to identify risk factors for complications of CDI (cCDI). Methods. Adult inpatients with confirmed CDI in 10 Canadian hospitals were enrolled and followed for 90 days. Potential risk factors were measured within 24 hours of diagnosis. Isolates were typed by polymerase chain reaction ribotyping. cCDI was defined as 1 or more of the following: colonic perforation, toxic megacolon, colectomy, admission to an intensive care unit for cCDI, or if CDI contributed to death within 30 days of enrollment. Risk factors for cCDI were investigated by logistic regression. Results. A total of 1380 patients were enrolled. cCDI was observed in 8% of patients. The ribotype was identified in 922 patients, of whom 52% were infected with R027. Age >= 80 years, heart rate > 90/minute, respiratory rate > 20/minute, white cell count < 4 x 10(9)/L or >= 20 x 10(9)/L, albumin < 25 g/L, blood urea nitrogen > 7 mmol/L, and C-reactive protein >= 150 mg/L were independently associated with cCDI. A higher frequency of cCDI was observed among R027-infected patients (10.9% vs 7.2%), but the association was not significant in adjusted analysis. Conclusions. CDI complications were associated with older age, abnormal blood tests, and abnormal vital signs. These factors, which are readily available to clinicians at the time of diagnosis, could be used for outcome prediction and risk stratification to select patients who may need closer monitoring or more aggressive therapy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

Similar duration of viral shedding of the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta variant between vaccinated and incompletely vaccinated individuals

Christopher E. Kandel, Andra Banete, Maureen Taylor, Andrea Llanes, Janine McCready, Gloria Crowl, Matthew Young, Angel X. Li, Emily Chien, Winfield Yim, Lily Yip, Robert Kozak, Allison J. McGeer, Samira Mubareka, Jeff E. Powis

Summary: There was no difference in viral shedding between outpatients with coronavirus disease 2019 (COVID-19) due to the severe acute respiratory coronavirus virus 2 (SARS-CoV-2) delta (delta) variant who received 2 vaccine doses at 7 days after symptom onset and those who did not receive the vaccine, with SARS-CoV-2 cultured from 2 (7%) of 28 and 1 (4%) of 26 outpatients, respectively.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Letter Public, Environmental & Occupational Health

Severity of SARS-CoV-2 omicron infection in vaccinated and unvaccinated residents of long-term care homes

Ahmed Vanker, Lara de Waal, Allison McGeer, Matthew Morgan

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Letter Immunology

Environmental Testing of Surfaces in the Room of a Patient With Monkeypox

Matthew P. Muller, Sharmistha Mishra, Allison McGeer, Samir Patel, Jonathan Gubbay, Maan Hasso, Adrienne K. Chan, Robert Kozak, Jerome A. Leis, Darrell S. Tan

CLINICAL INFECTIOUS DISEASES (2023)

Article Immunology

Adverse Events Following Immunization With mRNA and Viral Vector Vaccines in Individuals With Previous Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection From the Canadian National Vaccine Safety Network

Julie A. Bettinger, Michael A. Irvine, Hennady P. Shulha, Louis Valiquette, Matthew P. Muller, Otto G. Vanderkooi, James D. Kellner, Karina A. Top, Manish Sadarangani, Allison McGeer, Jennifer E. Isenor, Kimberly Marty, Phyumar Soe, Gaston De Serres

Summary: This study examined the short-term safety of COVID-19 vaccines in adults with a previous history of SARS-CoV-2 infection. It found that adults with moderate or severe previous infection were more likely to experience health events after each vaccine dose, while the risk associated with previous infection was attenuated after subsequent doses.

CLINICAL INFECTIOUS DISEASES (2023)

Article Genetics & Heredity

Genome screening, reporting, and genetic counseling for healthy populations

Selina Casalino, Erika Frangione, Monica Chung, Georgia MacDonald, Sunakshi Chowdhary, Chloe Mighton, Hanna Faghfoury, Yvonne Bombard, Lisa Strug, Trevor J. Pugh, Jared Simpson, Saranya Arnoldo, Navneet Aujla, Erin Bearss, Alexandra Binnie, Bjug Borgundvaag, Howard Chertkow, Marc Clausen, Marc Dagher, Luke Devine, David Di Iorio, Steven Marc Friedman, Chun Yiu Jordan Fung, Anne-Claude Gingras, Lee W. Goneau, Deepanjali Kaushik, Zeeshan Khan, Elisa Lapadula, Tiffany Lu, Tony Mazzulli, Allison McGeer, Shelley L. McLeod, Gregory Morgan, David Richardson, Harpreet Singh, Seth Stern, Ahmed Taher, Iris Wong, Natasha Zarei, Elena Greenfeld, Limin Hao, Matthew Lebo, William Lane, Abdul Noor, Jennifer Taher, Jordan Lerner-Ellis

Summary: Rapid advancements in genome sequencing technology have improved our understanding of the relationship between genes and human disease. This study collected blood samples from COVID-19 patients and performed genome sequencing to analyze the data. The researchers developed a comprehensive report that includes information on disease risks, genetic variants, and ancestry. They emphasize the importance of genetic counseling and offer counseling and referrals for clinically significant findings.

HUMAN GENETICS (2023)

Article Immunology

Invasive Pneumococcal Disease in High-risk Children: A 10-Year Retrospective Study

Jacqui van Warmerdam, Aaron Campigotto, Ari Bitnun, Georgina MacDougall, Melanie Kirby-Allen, Blake Papsin, Allison McGeer, Upton Allen, Shaun K. Morris

Summary: Despite the availability of pneumococcal vaccines, children with high-risk conditions are still susceptible to invasive pneumococcal disease. Insufficient vaccination is the main factor contributing to the occurrence of the disease.

PEDIATRIC INFECTIOUS DISEASE JOURNAL (2023)

Correction Microbiology

Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission (vol 7, pg 2011, 2022)

Bradley Pickering, Oliver Lung, Finlay Maguire, Peter Kruczkiewicz, Jonathon D. Kotwa, Tore Buchanan, Marianne Gagnier, Jennifer L. Guthrie, Claire M. Jardine, Alex Marchand-Austin, Ariane Masse, Heather McClinchey, Kuganya Nirmalarajah, Patryk Aftanas, Juliette Blais-Savoie, Hsien-Yao Chee, Emily Chien, Winfield Yim, Andra Banete, Bryan D. Griffin, Lily Yip, Melissa Goolia, Matthew Suderman, Mathieu Pinette, Greg Smith, Daniel Sullivan, Josip Rudar, Oksana Vernygora, Elizabeth Adey, Michelle Nebroski, Guillaume Goyette, Andres Finzi, Genevieve Laroche, Ardeshir Ariana, Brett Vahkal, Marceline Cote, Allison J. McGeer, Larissa Nituch, Samira Mubareka, Jeff Bowman

NATURE MICROBIOLOGY (2023)

Article Immunology

Evaluating the Impact of Statin Use on Influenza Vaccine Effectiveness and Influenza Infection in Older Adults

Hannah Chung, Michael A. Campitelli, Sarah A. Buchan, Aaron Campigotto, Branson Chen, Natasha S. Crowcroft, Vinita Dubey, Jonathan B. Gubbay, Timothy Karnauchow, Kevin Katz, Allison J. McGeer, J. Dayre McNally, Samira Mubareka, Michelle Murti, David C. Richardson, Laura C. Rosella, Kevin L. Schwartz, Marek Smieja, George Zahariadis, Jeffrey C. Kwong

Summary: The effectiveness of influenza vaccine against laboratory-confirmed influenza was similar between statin users and nonusers. However, statin users had a higher risk of influenza infection compared to nonusers, regardless of vaccination status. This study suggests that statin use may affect the effectiveness of influenza vaccine and increase the risk of influenza infection.

CLINICAL INFECTIOUS DISEASES (2023)

Article Public, Environmental & Occupational Health

Coronavirus disease 2019 (COVID-19) outbreak on an in-patient medical unit associated with unrecognized exposures in common areas-Epidemiological and whole-genome sequencing investigation

Dylan C. Kain, Sandra Isabel, Mariana Abdulnoor, Karel Boissinot, Richard De Borja, Amanda Filkin, Bernard Lam, Jason Li, Ilinca Lungu, Liz McCreight, Allison McGeer, Tony Mazzulli, Aimee Paterson, Philip Zuzarte, Felicia Vincelli, Cassandra Bergwerff, Ramzi Fattouh, Jared T. Simpson, Jennie Johnstone

Summary: During the COVID-19 pandemic, a severe SARS-CoV-2 outbreak occurred in a hospital in Toronto, Canada, from November 2020 to January 2021. The outbreak involved 8 patients and 10 staff and resulted in 3 patient deaths. Investigation revealed that patients cared for in geriatric chairs at the nursing station were at high risk for both acquiring and transmitting SARS-CoV-2. Therefore, it is important to consider the risk of informal patient care settings and prioritize room-based care during high-risk periods or outbreaks.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2023)

Article Economics

The epidemiology and healthcare costs of community-acquired pneumonia in Ontario, Canada: a population-based cohort study

Ryan O'Reilly, Hong Lu, Jeffrey C. C. Kwong, Allison McGeer, Teresa To, Beate Sander

Summary: The present study aimed to determine the short- and long-term healthcare costs associated with community-acquired pneumonia (CAP) from the healthcare payer perspective in Ontario, Canada. Through a retrospective population-based matched cohort study, it was found that CAP is associated with significantly increased acute and long-term healthcare costs compared to unexposed subjects. This study highlights the burden of CAP in both the inpatient and outpatient setting, and will inform strategic healthcare planning for future interventions and healthcare programs.

JOURNAL OF MEDICAL ECONOMICS (2023)

Article Microbiology

Clostridioides difficile S-Layer Protein A (SlpA) Serves as a General Phage Receptor

Alexia L. M. Royer, Andrew A. Umansky, Marie-Maude Allen, Julian R. Garneau, Maicol Ospina-Bedoya, Joseph A. Kirk, Gregory Govoni, Robert P. Fagan, Olga Soutourina, Louis-Charles Fortier

Summary: Therapeutic bacteriophages are being considered as alternatives to treat Clostridioides difficile infections. The surface layer protein A (SlpA) is identified as a common receptor used by many phages, which is a significant discovery for the rational design of therapeutic phage cocktails.

MICROBIOLOGY SPECTRUM (2023)

Article Pharmacology & Pharmacy

Comparison of Fracture Identification Using Different Definitions in Healthcare Administrative (Claims) Data

Natalia Konstantelos, Andrea M. Burden, Angela M. Cheung, Sandra Kim, Paul Grootendorst, Suzanne M. Cadarette

Summary: This study aimed to compare fracture rates estimated using different definitions and found that coding decisions have a significant impact on fracture outcome definitions. The study highlights the importance and impact of coding decisions on fracture outcome identification and emphasizes the need for further research to inform best practice in fracture outcome identification.

PHARMACY (2023)

Article Infectious Diseases

Use of whole genome sequencing to identify low-frequency mutations in SARS-CoV-2 patients treated with remdesivir

Kuganya Nirmalarajah, Winfield Yim, Patryk Aftanas, Angel X. Li, Altynay Shigayeva, Lily Yip, Zoe Zhong, Allison J. Mcgeer, Finlay Maguire, Samira Mubareka, Robert Kozak

Summary: This study investigated the effects of Remdesivir (RDV) treatment on intra-host SARS-CoV-2 diversity and low-frequency mutations in moderately ill hospitalized COVID-19 patients. The results showed minimal intra-host variability and few low-frequency variants in patients receiving short courses of RDV, suggesting little selective pressure.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Chemistry, Physical

Suspension plasma sprayed copper-graphene coatings for improved antibacterial properties

Taki Aissou, Jessica Jann, Nathalie Faucheux, Louis-Charles Fortier, Nadi Braidy, Jocelyn Veilleux

Summary: A new method was developed to spray a uniform composite coating of copper nanoparticles and graphene nanoflakes onto a metal substrate using an inductively-coupled radio frequency plasma torch. The resulting coatings exhibited microstructural uniformity, strong coating splats cohesion, and good retention and dispersion of graphene nanoflakes within the copper matrix. Moreover, the copper-graphene composite coatings showed strong antibacterial properties, achieving a 99% reduction of Escherichia coli bacteria within 1 hour.

APPLIED SURFACE SCIENCE (2023)

Letter Immunology

Environmental Surface Contamination With Monkeypox Virus in the Ambulatory Setting in Toronto, Canada

Sharon Sukhdeo, Matthew Muller, Allison McGeer, Jerome A. Leis, Adrienne Chan, Jonathan B. Gubbay, Samir Patel, Saman Khan, Stephen Perusini, Xinliu Angel Li, Robert Kozak, Sharmistha Mishra, Darrell H. S. Tan, Christopher Kandel

OPEN FORUM INFECTIOUS DISEASES (2023)

暂无数据